Reports preliminary fourth quarter 2024 revenue in the range of approximately $19.2 million to $19.4 millionReports preliminary full-year 2024 ...

With more than 325,000 pumps installed worldwide, the Plum A+™ general purpose infusion system remains ... Deliver secondary infusions via IV container or syringe ...

Lake Street analyst Frank Takkinen reiterated a Buy rating on Iradimed (IRMD – Research Report) today and set a price target of $60.00. The ...

Symbiq raises the bar for infusion pump technology with an innovative and user-centric approach. With its unique combination of nurse-friendly features, auto-default to safety software ...

Harsoria said it will use the funding to expand its manufacturing capabilities, improve research and development (R&D) ...

Baxter is still recovering from the temporary shutdown of its intravenous and peritoneal fluid manufacturing plant in Marion, ...

This study aimed to evaluate the efficacy and safety of a method that optimizes background infusion (BI) alongside PCA for titrating intravenous (IV) morphine in managing cancer-related pain.

Elevated patient expectations and sizable geriatric cohorts boost device advancements, from neuromodulators to remote ...

10, 2024 — In a single IV injection, a gene therapy targeting ... The therapy increases the amount of blood the heart can pump and dramatically improves ... Sep. 25, 2024 — Adults with ...

Although, preclinical data suggest that the behavioral expression of opioid use is similar between male and female rodents, we do not have conclusive results on sex differences on craving and relapse ...